ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,545,513 | -31.6% | 323,832 | +2.3% | 0.01% | -28.6% |
| Q2 2023 | $56,385,909 | +12.6% | 316,437 | +4.3% | 0.01% | 0.0% |
| Q1 2023 | $50,063,050 | +107924.9% | 303,486 | +3.1% | 0.01% | 0.0% |
| Q4 2022 | $46,344 | -99.9% | 294,286 | +5.3% | 0.01% | +16.7% |
| Q3 2022 | $42,102,000 | -7.3% | 279,566 | +1.2% | 0.01% | -14.3% |
| Q2 2022 | $45,410,000 | -25.9% | 276,237 | +0.3% | 0.01% | -12.5% |
| Q1 2022 | $61,298,000 | -3.9% | 275,325 | +2.5% | 0.01% | 0.0% |
| Q4 2021 | $63,764,000 | +5.6% | 268,665 | +3.8% | 0.01% | 0.0% |
| Q3 2021 | $60,406,000 | +13.9% | 258,833 | +0.4% | 0.01% | +14.3% |
| Q2 2021 | $53,038,000 | +2.3% | 257,719 | +2.1% | 0.01% | -12.5% |
| Q1 2021 | $51,870,000 | -0.3% | 252,487 | +4.1% | 0.01% | -11.1% |
| Q4 2020 | $52,016,000 | +24.3% | 242,511 | +5.9% | 0.01% | +12.5% |
| Q3 2020 | $41,845,000 | -3.8% | 228,963 | -2.9% | 0.01% | -11.1% |
| Q2 2020 | $43,479,000 | -7.6% | 235,902 | +1.2% | 0.01% | -25.0% |
| Q1 2020 | $47,035,000 | -44.0% | 233,114 | -48.1% | 0.01% | +33.3% |
| Q4 2019 | $83,980,000 | +141.5% | 448,804 | +106.0% | 0.01% | +12.5% |
| Q3 2019 | $34,768,000 | -29.1% | 217,848 | +11.9% | 0.01% | -33.3% |
| Q2 2019 | $49,024,000 | +16.2% | 194,611 | +10.4% | 0.01% | +9.1% |
| Q1 2019 | $42,195,000 | -45.2% | 176,307 | -47.4% | 0.01% | -8.3% |
| Q4 2018 | $76,952,000 | +72.6% | 335,116 | +112.5% | 0.01% | -7.7% |
| Q3 2018 | $44,586,000 | +1.9% | 157,693 | +5.8% | 0.01% | 0.0% |
| Q2 2018 | $43,774,000 | +22.3% | 149,073 | +5.1% | 0.01% | +8.3% |
| Q1 2018 | $35,792,000 | +21.6% | 141,808 | +4.1% | 0.01% | +20.0% |
| Q4 2017 | $29,434,000 | +19.2% | 136,271 | +2.5% | 0.01% | +11.1% |
| Q3 2017 | $24,703,000 | +10.3% | 132,922 | +2.4% | 0.01% | 0.0% |
| Q2 2017 | $22,399,000 | +18.6% | 129,851 | +5.0% | 0.01% | +12.5% |
| Q1 2017 | $18,891,000 | -4.3% | 123,719 | -7.7% | 0.01% | -11.1% |
| Q4 2016 | $19,743,000 | +25.8% | 133,990 | +7.9% | 0.01% | +12.5% |
| Q3 2016 | $15,688,000 | +13.9% | 124,135 | +1.6% | 0.01% | +14.3% |
| Q2 2016 | $13,778,000 | +15.9% | 122,207 | +7.0% | 0.01% | +16.7% |
| Q1 2016 | $11,889,000 | +8.1% | 114,208 | +17.1% | 0.01% | 0.0% |
| Q4 2015 | $10,996,000 | +0.8% | 97,502 | -2.1% | 0.01% | -14.3% |
| Q3 2015 | $10,909,000 | +14.6% | 99,630 | +0.1% | 0.01% | +40.0% |
| Q2 2015 | $9,517,000 | +4.6% | 99,496 | +1.8% | 0.01% | 0.0% |
| Q1 2015 | $9,100,000 | +13.3% | 97,712 | -0.3% | 0.01% | 0.0% |
| Q4 2014 | $8,030,000 | +57.2% | 98,052 | +23.2% | 0.01% | +66.7% |
| Q3 2014 | $5,107,000 | +5.6% | 79,575 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $4,836,000 | +10.4% | 79,533 | +8.7% | 0.00% | 0.0% |
| Q1 2014 | $4,379,000 | -9.1% | 73,134 | -3.3% | 0.00% | 0.0% |
| Q4 2013 | $4,820,000 | +12.5% | 75,667 | +20.0% | 0.00% | 0.0% |
| Q3 2013 | $4,283,000 | -2.2% | 63,047 | +3.7% | 0.00% | -25.0% |
| Q2 2013 | $4,381,000 | – | 60,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |